Skip to main content

Table 1 Eligibility criteria for the INFORM RSV study

From: Global molecular diversity of RSV – the “INFORM RSV” study

Inclusion CriteriaExclusion Criteria
Age < 5 yearsUse of palivizumab or experimental medication for RSV
Confirmed RSV positive diagnosis 
Written informed parental consent